SGLT-2 inhibitors for people with type 2 diabetes

Affiliations

¹ Department of Medicine, Geriatric Clinic, University of Helsinki, Helsinki FIN-00029 HUS, Finland; Department of Medicine, Helsinki University Hospital, Helsinki, Finland; Center for Life Course Health Research, University of Oulu, Oulu, Finland. Electronic address: timo.strandberg@helsinki.fi.
² Section of Geriatrics, Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
³ Department of Geriatrics, FHU CARTAGE, Centre hospitalier régional et universitaire de Nancy, and INSERM 1116, Université de Lorraine, Nancy, France.

Comment

Timo E Strandberg et al. Lancet. 2019.

. 2019 Aug 17;394(10198):560.

doi: 10.1016/S0140-6736(19)30719-6.

¹ Department of Medicine, Geriatric Clinic, University of Helsinki, Helsinki FIN-00029 HUS, Finland; Department of Medicine, Helsinki University Hospital, Helsinki, Finland; Center for Life Course Health Research, University of Oulu, Oulu, Finland. Electronic address: timo.strandberg@helsinki.fi.
² Section of Geriatrics, Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
³ Department of Geriatrics, FHU CARTAGE, Centre hospitalier régional et universitaire de Nancy, and INSERM 1116, Université de Lorraine, Nancy, France.

No abstract available

Comment in

SGLT-2 inhibitors for people with type 2 diabetes - Authors' reply.
Zelniker TA, Wiviott SD, Raz I, Sabatine MS. Zelniker TA, et al. Lancet. 2019 Aug 17;394(10198):560-561. doi: 10.1016/S0140-6736(19)30699-3. Lancet. 2019. PMID: 31423992 No abstract available.

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RHM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS. Zelniker TA, et al. Lancet. 2019 Jan 5;393(10166):31-39. doi: 10.1016/S0140-6736(18)32590-X. Epub 2018 Nov 10. Lancet. 2019. PMID: 30424892